These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28541748)

  • 1. Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer.
    Gould MK; Munoz-Plaza CE; Hahn EE; Lee JS; Parry C; Shen E
    Ann Am Thorac Soc; 2017 Oct; 14(10):1571-1580. PubMed ID: 28541748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer.
    Hahn EE; Gould MK; Munoz-Plaza CE; Lee JS; Parry C; Shen E
    J Natl Compr Canc Netw; 2018 Jan; 16(1):23-34. PubMed ID: 29295878
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
    Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
    Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
    Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
    Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center.
    Lee CC; Ho HC; Su YC; Chen PC; Yu CH; Yang CC
    Auris Nasus Larynx; 2016 Jun; 43(3):322-9. PubMed ID: 26642942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
    Castro MA; Dedivitis RA; Ribeiro KC
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors associated with interventional bronchoscopy in lung cancer.
    Guibert N; Mazieres J; Lepage B; Plat G; Didier A; Hermant C
    Ann Thorac Surg; 2014 Jan; 97(1):253-9. PubMed ID: 24094520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Singh N; Singh PS; Aggarwal AN; Behera D
    Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.
    Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M
    Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.
    Seigneurin A; Delafosse P; Trétarre B; Woronoff AS; Velten M; Grosclaude P; Guizard AV; Lapôtre-Ledoux B; Bara S; Molinié F; Colonna M
    BMC Cancer; 2018 Nov; 18(1):1091. PubMed ID: 30419850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
    Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
    Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.
    Clément-Duchêne C; Stock S; Xu X; Chang ET; Gomez SL; West DW; Wakelee HA; Gould MK
    Ann Am Thorac Soc; 2016 Jan; 13(1):58-66. PubMed ID: 26730864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
    Stevens W; Stevens G; Kolbe J; Cox B
    J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.